Tyenne 20 mg/mL concentrate for solution for infusion
*Company:
Fresenius Kabi LtdStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 19 December 2023
File name
Tyenne Patient Brochure IRELAND (1).pdf
Reasons for updating
- Replace File
Updated on 19 December 2023
File name
Tyenne Patient Alert Card IRELAND COMPACT.pdf
Reasons for updating
- Replace File
Updated on 06 December 2023
File name
Tyenne Healthcare Professional Brochure IRELAND (2).pdf
Reasons for updating
- Add New Doc
Updated on 06 December 2023
File name
Tyenne Dosing Guide IRELAND.pdf
Reasons for updating
- Add New Doc
Updated on 06 December 2023
File name
Tyenne Patient Brochure IRELAND (1).pdf
Reasons for updating
- Add New Doc
Updated on 06 December 2023
File name
Tyenne Patient Alert Card IRELAND COMPACT.pdf
Reasons for updating
- Add New Doc
Updated on 01 November 2023
File name
IE-SmPC-tyenne-Vial-v001.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 01 November 2023
File name
PIL Vial.pdf
Reasons for updating
- New PIL for new product